Literature DB >> 8536162

The effect of octreotide on human gastric compliance and sensory perception.

H Mertz1, J H Walsh, B Sytnik, E A Mayer.   

Abstract

Somatostatin or its analogue octreotide (OCT) has previously been shown to modulate gastric emptying, intestinal motor activity and visceral sensation. In the current study we sought to determine the effect of a single dose of OCT (1.25 micrograms kg-1 s.c.), which has previously been shown to have both motor and sensory effects, on proximal gastric compliance and on conscious perception of gastric distention. Gastric distention was performed in 13 healthy male volunteers, by either slow ramp distention (60 ml min-1) or by intermittent pressure steps (phasic distention; 4-20 mmHg) using an electronic distention device. Compliance curves (pressure-volume relationship), and thresholds for innocuous (fullness) and noxious sensations (discomfort, pain) were determined following vehicle or OCT injection. OCT consistently and significantly reduced the rate of the gastric accommodation reflex by 50%, resulting in a reduced compliance at distention pressures greater than 10 mmHg during phasic distention. In contrast, no effect was observed on the compliance curve obtained during ramp distention. OCT selectively increased the threshold for fullness during both ramp and phasic distention. During phasic distention, OCT decreased the volume thresholds for noxious (pain) sensations experienced at volumes greater than 300 ml, without affecting the corresponding pressure threshold. These findings suggest that at low distension volumes, OCT in the dosage used has a direct inhibitory effect on afferents mediating innocuous gastric sensations. The hyperalgesic effect observed during phasic distention may be secondary to OCT's inhibitory effect on the gastric accommodation reflex.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8536162     DOI: 10.1111/j.1365-2982.1995.tb00223.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  7 in total

1.  Augmented Visceral Perception.

Authors:  William L. Hasler
Journal:  Curr Treat Options Gastroenterol       Date:  2001-08

2.  Postfundoplication Complications in Children.

Authors:  Susan R. Orenstein; Carlo Di Lorenzo
Journal:  Curr Treat Options Gastroenterol       Date:  2001-10

3.  Evidence for two distinct perceptual alterations in irritable bowel syndrome.

Authors:  B D Naliboff; J Munakata; S Fullerton; R H Gracely; A Kodner; F Harraf; E A Mayer
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

Review 4.  The role of experimental models in developing new treatments for irritable bowel syndrome.

Authors:  Daniel P Holschneider; Sylvie Bradesi; Emeran A Mayer
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 3.869

5.  Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans.

Authors:  A Foxx-Orenstein; M Camilleri; D Stephens; D Burton
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

6.  Symptoms and visceral perception in severe functional and organic dyspepsia.

Authors:  H Mertz; S Fullerton; B Naliboff; E A Mayer
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

Review 7.  Functional GI disorders: from animal models to drug development.

Authors:  E A Mayer; S Bradesi; L Chang; B M R Spiegel; J A Bueller; B D Naliboff
Journal:  Gut       Date:  2007-10-26       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.